Tuesday, July 23, 2013

Novel chemotherapy topic discovered through quantitative proteomics!

A common criticism of Proteomics is the lack of true chemotherapeutics that have resulted from discovery studies.  (I hope I don't have to say that I disagree strongly with this point).  But I do hear it out there.

A new paper from Henrik Johannson et. al., out of the Karolinksa Institute (Sweden) and just released in Nature Communications describes a new chemotherapeutic target, retinoic acid receptor alpha (RARA) that was discovered almost solely by quantitative proteomics.  You can read the paper, open access, here.

Take that, naysayers!

No comments:

Post a Comment